Barely Significant
← all excerpts

Evaluation of the safety of imatinib mesylate in 200 iraqi patients with chronic myeloid leukemia in the chronic phase: single-center study.

Turk J Haematol · 2013 · PMC3874977 · PMID 24385829

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantP<0.001actually significant
Paresthesia was found in 15%, which was not proven by electromyography or nerve conduction study; this was highly significant in females (P<0.001), which may be due to hypophosphatemia, hypocalcemia, and hypomagnesemia caused either by the imatinib or NSAIDs.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.